thyroid cancer
Duke Cancer Institute Expanding Molecular Tumor Board Access to Rural, Underserved Communities
Premium
The MTB expansion will initially focus on patients with lung and thyroid cancers in several rural counties in North Carolina.
Seattle Cancer Care Alliance Aims to Improve Molecular Profiling Access for Thyroid Cancer Patients
Premium
The project is focused on building a workflow to improve guideline-concordant molecular testing, which researchers hope will reduce insurance denials and improve community access.
CHOP Researchers Find Gene Fusions are Harbingers of Aggressive Disease in Pediatric Thyroid Cancer
Premium
The findings could have treatment implications and encourage greater comprehensive genomic profiling in more young cancer patients.
CMS No Longer Reimbursing Interpace Bio Thyroid Tests; Firm's Rights Offering Terminated
CMS has issued a new billing policy and will no longer reimburse for the use of Interpace's ThyGeNext and ThyraMir thyroid cancer tests under certain conditions.
Pan-Cancer Analysis Reveals Unique Features in Tumors From Younger People
Tumors in younger individuals exhibited a dysregulated molecular aging phenotype and were associated with hallmarks of premature senescence.
Mar 11, 2021